Report Detail
Global Retinal Vein Occlusion Therapeutics Market Insights, Forecast to 2025
- RnM3041369 |
- 05 March, 2019 |
- Global |
- 129 Pages |
- QYResearch |
- Pharma & Healthcare
The global Retinal Vein Occlusion Therapeutics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Retinal Vein Occlusion Therapeutics market based on company, product type, end user and key regions.
This report studies the global market size of Retinal Vein Occlusion Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Retinal Vein Occlusion Therapeutics in these regions.
This research report categorizes the global Retinal Vein Occlusion Therapeutics market by top players/brands, region, type and end user. This report also studies the global Retinal Vein Occlusion Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Acucela Inc
Addmedica SAS
Aerpio Therapeutics Inc
Annexin Pharmaceuticals AB
Chengdu Kanghong Pharmaceuticals Group Co Ltd
Clearside BioMedical Inc
Formycon AG
Graybug Vision Inc
Kala Pharmaceuticals Inc
Lupin Ltd
Mabion SA
Novartis AG
Ocular Therapeutix Inc
Ohr Pharmaceutical Inc
Regeneron Pharmaceuticals Inc
SciFluor Life Sciences LLC
ThromboGenics NV
Market size by Product
Aflibercept Biosimilar
Aflibercept SR
AKB-9778
AP-01
Others
Market size by End User
Research Center
Clinic
Hospital
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Retinal Vein Occlusion Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Retinal Vein Occlusion Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Retinal Vein Occlusion Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Retinal Vein Occlusion Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Retinal Vein Occlusion Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Retinal Vein Occlusion Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Retinal Vein Occlusion Therapeutics Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Retinal Vein Occlusion Therapeutics Market Size Growth Rate by Product
- 1.4.2 Aflibercept Biosimilar
- 1.4.3 Aflibercept SR
- 1.4.4 AKB-9778
- 1.4.5 AP-01
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Retinal Vein Occlusion Therapeutics Market Size Growth Rate by End User
- 1.5.2 Research Center
- 1.5.3 Clinic
- 1.5.4 Hospital
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Retinal Vein Occlusion Therapeutics Market Size
- 2.1.1 Global Retinal Vein Occlusion Therapeutics Revenue 2014-2025
- 2.1.2 Global Retinal Vein Occlusion Therapeutics Sales 2014-2025
- 2.2 Retinal Vein Occlusion Therapeutics Growth Rate by Regions
- 2.2.1 Global Retinal Vein Occlusion Therapeutics Sales by Regions
- 2.2.2 Global Retinal Vein Occlusion Therapeutics Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Retinal Vein Occlusion Therapeutics Sales by Manufacturers
- 3.1.1 Retinal Vein Occlusion Therapeutics Sales by Manufacturers
- 3.1.2 Retinal Vein Occlusion Therapeutics Sales Market Share by Manufacturers
- 3.1.3 Global Retinal Vein Occlusion Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Retinal Vein Occlusion Therapeutics Revenue by Manufacturers
- 3.2.1 Retinal Vein Occlusion Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Retinal Vein Occlusion Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.3 Retinal Vein Occlusion Therapeutics Price by Manufacturers
- 3.4 Retinal Vein Occlusion Therapeutics Manufacturing Base Distribution, Product Types
- 3.4.1 Retinal Vein Occlusion Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Retinal Vein Occlusion Therapeutics Product Type
- 3.4.3 Date of International Manufacturers Enter into Retinal Vein Occlusion Therapeutics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Retinal Vein Occlusion Therapeutics Sales by Product
- 4.2 Global Retinal Vein Occlusion Therapeutics Revenue by Product
- 4.3 Retinal Vein Occlusion Therapeutics Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Retinal Vein Occlusion Therapeutics Breakdown Data by End User
6 North America
- 6.1 North America Retinal Vein Occlusion Therapeutics by Countries
- 6.1.1 North America Retinal Vein Occlusion Therapeutics Sales by Countries
- 6.1.2 North America Retinal Vein Occlusion Therapeutics Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Retinal Vein Occlusion Therapeutics by Product
- 6.3 North America Retinal Vein Occlusion Therapeutics by End User
7 Europe
- 7.1 Europe Retinal Vein Occlusion Therapeutics by Countries
- 7.1.1 Europe Retinal Vein Occlusion Therapeutics Sales by Countries
- 7.1.2 Europe Retinal Vein Occlusion Therapeutics Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Retinal Vein Occlusion Therapeutics by Product
- 7.3 Europe Retinal Vein Occlusion Therapeutics by End User
8 Asia Pacific
- 8.1 Asia Pacific Retinal Vein Occlusion Therapeutics by Countries
- 8.1.1 Asia Pacific Retinal Vein Occlusion Therapeutics Sales by Countries
- 8.1.2 Asia Pacific Retinal Vein Occlusion Therapeutics Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Retinal Vein Occlusion Therapeutics by Product
- 8.3 Asia Pacific Retinal Vein Occlusion Therapeutics by End User
9 Central & South America
- 9.1 Central & South America Retinal Vein Occlusion Therapeutics by Countries
- 9.1.1 Central & South America Retinal Vein Occlusion Therapeutics Sales by Countries
- 9.1.2 Central & South America Retinal Vein Occlusion Therapeutics Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Retinal Vein Occlusion Therapeutics by Product
- 9.3 Central & South America Retinal Vein Occlusion Therapeutics by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Retinal Vein Occlusion Therapeutics by Countries
- 10.1.1 Middle East and Africa Retinal Vein Occlusion Therapeutics Sales by Countries
- 10.1.2 Middle East and Africa Retinal Vein Occlusion Therapeutics Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Retinal Vein Occlusion Therapeutics by Product
- 10.3 Middle East and Africa Retinal Vein Occlusion Therapeutics by End User
11 Company Profiles
- 11.1 Acucela Inc
- 11.1.1 Acucela Inc Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Acucela Inc Retinal Vein Occlusion Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Acucela Inc Retinal Vein Occlusion Therapeutics Products Offered
- 11.1.5 Acucela Inc Recent Development
- 11.2 Addmedica SAS
- 11.2.1 Addmedica SAS Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Addmedica SAS Retinal Vein Occlusion Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Addmedica SAS Retinal Vein Occlusion Therapeutics Products Offered
- 11.2.5 Addmedica SAS Recent Development
- 11.3 Aerpio Therapeutics Inc
- 11.3.1 Aerpio Therapeutics Inc Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Aerpio Therapeutics Inc Retinal Vein Occlusion Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Aerpio Therapeutics Inc Retinal Vein Occlusion Therapeutics Products Offered
- 11.3.5 Aerpio Therapeutics Inc Recent Development
- 11.4 Annexin Pharmaceuticals AB
- 11.4.1 Annexin Pharmaceuticals AB Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Annexin Pharmaceuticals AB Retinal Vein Occlusion Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Annexin Pharmaceuticals AB Retinal Vein Occlusion Therapeutics Products Offered
- 11.4.5 Annexin Pharmaceuticals AB Recent Development
- 11.5 Chengdu Kanghong Pharmaceuticals Group Co Ltd
- 11.5.1 Chengdu Kanghong Pharmaceuticals Group Co Ltd Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Chengdu Kanghong Pharmaceuticals Group Co Ltd Retinal Vein Occlusion Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Chengdu Kanghong Pharmaceuticals Group Co Ltd Retinal Vein Occlusion Therapeutics Products Offered
- 11.5.5 Chengdu Kanghong Pharmaceuticals Group Co Ltd Recent Development
- 11.6 Clearside BioMedical Inc
- 11.6.1 Clearside BioMedical Inc Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Clearside BioMedical Inc Retinal Vein Occlusion Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Clearside BioMedical Inc Retinal Vein Occlusion Therapeutics Products Offered
- 11.6.5 Clearside BioMedical Inc Recent Development
- 11.7 Formycon AG
- 11.7.1 Formycon AG Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Formycon AG Retinal Vein Occlusion Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Formycon AG Retinal Vein Occlusion Therapeutics Products Offered
- 11.7.5 Formycon AG Recent Development
- 11.8 Graybug Vision Inc
- 11.8.1 Graybug Vision Inc Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Graybug Vision Inc Retinal Vein Occlusion Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Graybug Vision Inc Retinal Vein Occlusion Therapeutics Products Offered
- 11.8.5 Graybug Vision Inc Recent Development
- 11.9 Kala Pharmaceuticals Inc
- 11.9.1 Kala Pharmaceuticals Inc Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Kala Pharmaceuticals Inc Retinal Vein Occlusion Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Kala Pharmaceuticals Inc Retinal Vein Occlusion Therapeutics Products Offered
- 11.9.5 Kala Pharmaceuticals Inc Recent Development
- 11.10 Lupin Ltd
- 11.10.1 Lupin Ltd Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Lupin Ltd Retinal Vein Occlusion Therapeutics Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Lupin Ltd Retinal Vein Occlusion Therapeutics Products Offered
- 11.10.5 Lupin Ltd Recent Development
- 11.11 Mabion SA
- 11.12 Novartis AG
- 11.13 Ocular Therapeutix Inc
- 11.14 Ohr Pharmaceutical Inc
- 11.15 Regeneron Pharmaceuticals Inc
- 11.16 SciFluor Life Sciences LLC
- 11.17 ThromboGenics NV
12 Future Forecast
- 12.1 Retinal Vein Occlusion Therapeutics Market Forecast by Regions
- 12.1.1 Global Retinal Vein Occlusion Therapeutics Sales Forecast by Regions 2019-2025
- 12.1.2 Global Retinal Vein Occlusion Therapeutics Revenue Forecast by Regions 2019-2025
- 12.2 Retinal Vein Occlusion Therapeutics Market Forecast by Product
- 12.2.1 Global Retinal Vein Occlusion Therapeutics Sales Forecast by Product 2019-2025
- 12.2.2 Global Retinal Vein Occlusion Therapeutics Revenue Forecast by Product 2019-2025
- 12.3 Retinal Vein Occlusion Therapeutics Market Forecast by End User
- 12.4 North America Retinal Vein Occlusion Therapeutics Forecast
- 12.5 Europe Retinal Vein Occlusion Therapeutics Forecast
- 12.6 Asia Pacific Retinal Vein Occlusion Therapeutics Forecast
- 12.7 Central & South America Retinal Vein Occlusion Therapeutics Forecast
- 12.8 Middle East and Africa Retinal Vein Occlusion Therapeutics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Retinal Vein Occlusion Therapeutics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Retinal Vein Occlusion Therapeutics . Industry analysis & Market Report on Retinal Vein Occlusion Therapeutics is a syndicated market report, published as Global Retinal Vein Occlusion Therapeutics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Retinal Vein Occlusion Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
